Christopher Little is recognised as a world leader in defining the molecular mechanisms of cartilage breakdown in osteoarthritis and developing methods for evaluating pre-clinical models for musculoskeletal disease research.
Share link:
Share link:
Christopher Little is recognised as a world leader in defining the molecular mechanisms of cartilage breakdown in osteoarthritis and developing methods for evaluating pre-clinical models for musculoskeletal disease research.